Free Trial

American Century Companies Inc. Has $1.05 Million Holdings in Maximus, Inc. $MMS

Maximus logo with Business Services background

Key Points

  • American Century Companies Inc. reduced its stake in Maximus, Inc. by 28.4%, selling 6,112 shares and retaining 15,435 shares valued at $1,053,000.
  • Maximus reported a quarterly earnings of $2.16 per share, surpassing expectations, with a revenue of $1.35 billion, up 2.5% from the previous year.
  • The company announced a quarterly dividend of $0.30 per share, resulting in an annualized dividend of $1.20 and a yield of 1.4%.
  • Five stocks to consider instead of Maximus.

American Century Companies Inc. lowered its position in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 28.4% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 15,435 shares of the health services provider's stock after selling 6,112 shares during the quarter. American Century Companies Inc.'s holdings in Maximus were worth $1,053,000 as of its most recent filing with the SEC.

A number of other institutional investors have also modified their holdings of MMS. LRI Investments LLC grew its stake in Maximus by 11.9% in the 1st quarter. LRI Investments LLC now owns 1,833 shares of the health services provider's stock valued at $125,000 after buying an additional 195 shares during the last quarter. Vestcor Inc grew its holdings in Maximus by 2.3% during the first quarter. Vestcor Inc now owns 9,877 shares of the health services provider's stock worth $674,000 after purchasing an additional 223 shares during the period. Cetera Investment Advisers grew its holdings in shares of Maximus by 5.8% during the 1st quarter. Cetera Investment Advisers now owns 4,519 shares of the health services provider's stock worth $308,000 after purchasing an additional 247 shares in the last quarter. UMB Bank n.a. increased its stake in shares of Maximus by 70.2% in the first quarter. UMB Bank n.a. now owns 606 shares of the health services provider's stock valued at $41,000 after buying an additional 250 shares during the period. Finally, Nisa Investment Advisors LLC lifted its position in shares of Maximus by 0.7% during the 1st quarter. Nisa Investment Advisors LLC now owns 39,936 shares of the health services provider's stock valued at $2,723,000 after acquiring an additional 290 shares during the period. Institutional investors and hedge funds own 97.21% of the company's stock.

Analysts Set New Price Targets

A number of analysts recently weighed in on MMS shares. Wall Street Zen downgraded Maximus from a "buy" rating to a "hold" rating in a research report on Thursday, May 15th. Zacks Research raised shares of Maximus from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, August 26th. One research analyst has rated the stock with a Strong Buy rating and one has assigned a Buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of "Strong Buy" and an average price target of $90.00.

Get Our Latest Analysis on Maximus

Maximus Stock Performance

NYSE MMS traded down $0.30 during trading hours on Monday, hitting $87.95. 190,219 shares of the stock were exchanged, compared to its average volume of 567,334. The company has a quick ratio of 2.27, a current ratio of 2.27 and a debt-to-equity ratio of 0.91. The company has a market cap of $4.96 billion, a price-to-earnings ratio of 16.18 and a beta of 0.61. Maximus, Inc. has a 12-month low of $63.77 and a 12-month high of $93.94. The stock has a 50-day moving average of $78.21 and a 200 day moving average of $72.43.

Maximus (NYSE:MMS - Get Free Report) last announced its earnings results on Thursday, August 7th. The health services provider reported $2.16 EPS for the quarter, beating the consensus estimate of $1.39 by $0.77. The business had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.29 billion. Maximus had a return on equity of 24.44% and a net margin of 5.83%.The company's revenue was up 2.5% on a year-over-year basis. During the same period last year, the business posted $1.74 EPS. Maximus has set its FY 2025 guidance at 7.350-7.550 EPS. As a group, equities research analysts forecast that Maximus, Inc. will post 6.15 earnings per share for the current year.

Maximus Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Sunday, August 31st. Stockholders of record on Friday, August 15th were given a dividend of $0.30 per share. The ex-dividend date was Friday, August 15th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.4%. Maximus's payout ratio is presently 22.10%.

About Maximus

(Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Featured Articles

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

Should You Invest $1,000 in Maximus Right Now?

Before you consider Maximus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.

While Maximus currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.